Discipline | Biomedicine, life sciences |
---|---|
Language | English |
Edited by | Detlef Weigel and Tim Behrens (interim co-Editors-in-Chief) |
Publication details | |
History | 2012–present |
Publisher | eLife Sciences Publications Ltd[1] |
Frequency | Continuous |
Yes | |
License | CC-BY 3.0, CC-BY 4.0, and CC0 |
6.4 (2023) | |
Standard abbreviations | |
ISO 4 | eLife |
Indexing | |
CODEN | ELIFA8 |
ISSN | 2050-084X |
OCLC no. | 813236730 |
Links | |
eLife is a not-for-profit, peer-reviewed, open access, science publisher for the biomedical and life sciences. It was established at the end of 2012 by the Howard Hughes Medical Institute, Max Planck Society, and Wellcome Trust, following a workshop held in 2010 at the Janelia Farm Research Campus. Together, these organizations provided the initial funding to support the business and publishing operations.[2] In 2016, the organizations committed US$26 million to continue publication of the journal.[3]
The most recent editor-in-chief was Michael Eisen (University of California, Berkeley).[4][5] Eisen was fired in October 2023, a controversial decision which led at least five editors to resign in protest.[6] eLife Deputy Editors Detlef Weigel and Tim Behrens were invited by the eLife Board of Directors to serve as co-Editors-in-Chief until the end of 2024.[7]
Editorial decisions are made largely by senior editors and members of the board of reviewing editors, all of whom are active scientists working in fields ranging from human genetics and neuroscience to biophysics, epidemiology, and ecology.[8]
:1
was invoked but never defined (see the help page).